Journal of the American Chemical Society
Article
Z = 4, T = 100 K, μ(Cu Kα) = 5.694 mm−1, Dcalcd = 1.722 g/mm3,
was filtered by cannula. The solvent was reduced to a minimal volume,
and the concentrated solution was added slowly to chilled, rapidly
stirred pentane (20 mL). The solid was isolated by cannula filtration
and then heated to 30 °C under high vacuum for 3 days, yielding 283
mg of a yellow powder (79%). Anal. Calcd (found) for
C71H41N3BF36IrO: C, 46.37 (46.53); H, 2.25 (2.22); N, 2.28 (2.20).
1H NMR (600 MHz, CD2Cl2, 5 °C): δ 8.70 (d, J = 6.0, 1H), 8.20 (s,
2H), 8.15 (s, 1H), 8.11 (d, J = 7.8, 1H), 8.05 (t, J = 7.8, 1H), 7.76 (s,
3H), 7.72 (s, 8H), 7.63 (d, J = 7.2, 1H), 7.54 (s, 4H), 7.45 (t, J = 6.6,
1H), 7.15 (t, J = 7.2, 1H), 7.09 (t, J = 7.2, 1H), 6.55 (d, J = 7.8, 1H),
1.48 (s, 15H). 13C{1H} NMR (150 MHz, CD2Cl2, 5 °C, one carbon
merged to others): δ 169.8, 162.9 (1:1:1:1 quartet, JC−B = 50), 156.1,
153.9, 147.1, 141.2, 139.7, 135.0, 134.2, 133.4 (q, 2-bond JC−F = 35),
131.5, 131.1, 131.0 (q, 2-bond JC−F = 33), 130.5, 130.4, 129.0 (q, 2-
bond JC−F = 29), 128.5, 126.3, 124.8 (q, 1-bond JC−F = 272), 125.2,
64683 reflections measured (3.72 ≤ 2θ ≤ 140.22), 11930 unique (Rint
=
0.0407), which were used in all calculations. The final R1 value was
0.0283 (I > 2σ(I)), the and wR2 value was 0.0695 (all data), with a
goodness of fit on F2 of 1.036. Anal. Calcd (found) for
C62H39N2BF30IrOCl: C, 45.51 (45.21); H, 2.40 (2.20); N, 1.71
1
(1.71). H NMR (600 MHz, CD2Cl2): δ 12.06 (s, 1H), 8.80 (d, J =
6.0, 1H), 8.12 (d, J = 4.2, 2H), 7.97 (s, 1H), 7.85 (dd, J = 7.8 and 1.8,
1H), 7.72 (s, 8H), 7.60 (overlapping triplets, J ≈ 5, 2H), 7.56 (s, 4H),
7.56 (overlapping d, 1H), 7.40 (td, J = 7.8 and 1.2, 1H), 7.33 (td, J = 7.8
and 1.2, 1H), 6.57 (dd, J = 7.8 and 0.6, 1H), 1.33 (s, 15H). 13C{1H}
NMR (150 MHz, CD2Cl2): δ 171.0, 162.1 (1:1:1:1 quartet, JC−B = 50),
154.9, 154.4, 142.9, 141.7, 135.1, 132.8, 132.6 (q, 2-bond JC−F = 35),
132.0, 131.8, 131.7, 130.0, 129.4, 129.2 (q, 2-bond JC−F = 32), 127.0,
126.3 (pseudo t, 3-bond JC−F = 3), 125.1, 125.0 (q, 1-bond JC−F = 272),
124.9, 122.6 (q, 1-bond JC−F = 272), 117.8 (pseudo t, 3-bond JC−F = 4),
90.2, 8.4.
124.7, 123.5 (pseudo t, 3-bond JC−F = 4), 123.2 (q, 1-bond JC−F
=
272), 122.0 (q, 1-bond JC−F = 272), 117.9, 117.7 (pseudo t, 3-bond
Synthesis of 3,5-Bis(trifluoromethyl)-N-(2-(2-pyridyl)-
phenyl)benzamide (8). A 2 dram acetylation vial was charged
with 200 mg of 2-(2-pyridyl)aniline (1.18 mmol), 124 mg of NEt3
(1.23 mmol), and 4 mL of dry dichloromethane and capped with a
septum. After it was stirred for 10 min, the reaction mixture was stirred
for an additional 10 min as the solution was cooled to 0 °C. A 321 mg
aliquot of 3,5-bis(trifluoromethyl)benzoyl chloride (1.16 mmol) was
injected via syringe, and the reaction mixture was stirred overnight as
the ice bath melted. The next day, 10 mL of dichloromethane was
added, and the solution was washed once with water and twice with
1 M aqueous NaOH. The organic layer was dried with MgSO4 and
filtered, and the solvent was removed under reduced pressure. The
crude product was chromatographed on silica gel using ethyl acetate/
hexane (15/85 v/v, Rf = 0.28), and 414 mg of a white solid was
isolated (87%). Anal. Calcd (found) for C20H12N2F6O: C, 58.54
(58.80); H, 2.95 (3.02); N, 6.83 (6.72). 1H NMR (500 MHz,
CD2Cl2): δ 14.01 (s, N−H, 1H), 8.80 (d, J = 8.0, 1H), 8.69 (d, J = 5.0,
1H), 8.56 (s, 2H), 8.09 (s, 1H), 7.93 (m, 2H), 7.86 (dd, J = 8.0 and
1.0, 1H), 7.51 (td, J = 7.5 and 1.0, 1H), 7.38 (td, J = 5.0 and 3.0, 1H),
7.28 (t, J = 7.5, 1H). 13C{1H} NMR (150 MHz, CD2Cl2): δ 162.3,
158.2, 147.4, 138.6, 138.2, 132.3 (q, 2-bond JC−F = 33), 130.7, 129.1,
128.2, 128.1, 125.3, 125.2, 124.5, 123.6 (q, 1-bond JC−F = 271), 123.3,
122.8, 121.8.
JC−F = 4), 112.1, 90.8, 8.6.
Synthesis of [Ir(Cp*){(3,5-bis(trifluoromethyl)benzoyl)(2-(2-
pyridyl)phenyl)amide}(NCArMe)][B(ArF)4] (Int-NCArMe, 11). Com-
plex 9 (100 mg, 0.13 mmol), 127 mg of Na[B(ArF)4] (0.14 mmol),
NCArMe (p-tolunitrile, 17 μL, 0.14 mmol), and 20 mL of
dichloromethane were stirred for 2 h, at which point the mixture
was filtered by cannula. The solvent was reduced to a minimal volume,
and the concentrated solution was added slowly to chilled, rapidly
stirred pentane (20 mL). The solid was isolated by cannula filtration
and then heated to 40 °C under high vacuum overnight, yielding
148 mg of the product (67%). When 10 mg of 11 (0.006 mmol) and
14 mg of sPhIO (0.041 mmol) were mixed at −20 °C in dichloro-
1
methane-d2, the OC was observed in 53% yield after 45 min by H
NMR spectroscopy. Anal. Calcd (found) for C70H45N3BF30IrO: C,
48.96 (48.69); H, 2.64 (2.63); N, 2.45 (2.28). H NMR (500 MHz,
1
CD2Cl2): δ 8.72 (dd, J = 5.5 and 0.5, 1H), 8.11 (d, J = 7.5, 1H), 8.06
(td, J = 7.5 and 1.5, 1H), 7.75 (s, 3H), 7.73 (s, 8H), 7.62 (dd, J = 6.0
and 1.5, 1H), 7.56 (s, 4H), 7.53 (d, J = 8.0, 2H), 7.46 (td, J = 7.0 and
1.5, 1H), 7.27 (d, J = 8.0, 2H), 7.12 (td, J = 8.0 and 1.5, 1H), 7.06 (td,
J = 7.5 and 1.5, 1H), 6.50 (dd, J = 7.5 and 1.0, 1H), 2.38 (s, 3H), 1.49
(s, 15H). 13C{1H} NMR (150 MHz, CD2Cl2): δ 170.2, 162.1 (1:1:1:1
quartet, JC−B = 50), 156.4, 153.9, 147.8, 147.6, 141.1, 140.7, 135.2, 133.6,
131.3, 131.2 (q, 2-bond JC−F = 33), 131.1, 130.9, 130.7, 130.3, 129.3 (q, 2-
bond JC−F = 31), 128.7, 126.1, 125.0, 124.9 (q, 1-bond JC−F = 270), 124.4,
123.4 (q, 1-bond JC−F = 272), 123.3 (pseudo t, 3-bond JC−F = 4), 121.6,
117.8 (pseudo t, 3-bond JC−F = 4), 106.0, 90.3, 22.2, 8.7.
Synthesis of [Ir(Cp*){(3,5-bis(trifluoromethyl)benzoyl)(2-(2-
pyridyl)phenyl)amide}(OPy)][B(ArF)4] (Int-OPy, 12). Complex 9
(90 mg, 0.12 mmol), 114 mg of Na[B(ArF)4] (0.13 mmol), OPy
(pyridine N-oxide, 0.13 mmol), and 20 mL of dichloromethane were
stirred for 2 h, at which point the mixture was filtered by cannula. The
solvent was reduced to a minimal volume and the concentrated
solution was added slowly to chilled, rapidly stirred pentane (20 mL).
The solid was isolated by cannula filtration and then dried under high
vacuum overnight, yielding 150 mg of the red product (76%). Complex
12 was unstable in solution at room temperature after several hours.
When 10 mg of 12 (0.006 mmol) and 18 mg of sPhIO (0.053 mmol)
were mixed at −30 °C in dichloromethane-d2, the OC was observed in
98% yield after 25 min by 1H NMR spectroscopy. Anal. Calcd (found) for
C67H43N3BF30IrO2: C, 47.47 (47.18); H, 2.56 (2.49); N, 2.48 (2.29). 1H
NMR (500 MHz, CD2Cl2, −40 °C): δ 8.90 (d, J = 5.0, 1H), 8.07 (d, J =
7.5, 1H), 8.03 (t, J = 7.5, 1H), 7.74−7.70 (m, 5H), 7.71 (s, 8H), 7.54−
7.52 (m, 2H), 7.53 (s, 4H), 7.34 (t, J = 7.5, 1H), 7.11 (t, J = 7.0, 2H),
6.99 (t, J = 7.0, 1H), 6.94 (t, J = 7.5, 1H), 6.32 (d, J = 7.5, 1H), 1.26 (s,
15H). 13C{1H} NMR (125 MHz, CD2Cl2, −40 °C, one carbon merged
to others): δ 169.4, 161.6 (1:1:1:1 quartet, JC−B = 50), 155.2, 153.5, 146.6,
141.6, 140.4, 139.6, 138.3, 135.2, 134.5, 130.8, 130.6, 129.6, 129.3, 128.6
(q, 2-bond JC−F = 31), 125.9, 125.5, 124.3 (q, 1-bond JC−F = 271), 123.9,
123.5, 122.9, 122.8 (q, 1-bond JC−F = 271), 117.4, 86.2, 8.3.
Synthesis of Ir(Cp*)((3,5-bis(trifluoromethyl)benzoyl)(2-(2-
pyridyl)phenyl)amide)Cl (9). A mixture of 150 mg of NaH (6.25
mmol), 450 mg of proligand 8 (1.10 mmol), and 30 mL of THF were
stirred for 1.5 h and then filtered by cannula onto 400 mg of
[Ir(Cp*)(Cl)2]2 (0.50 mmol). The iridium dimer had been dried by
heating at 50 °C under high vacuum the previous night. After the
mixture was stirred for 24 h, the mixture was filtered by cannula and
the solvent was removed under reduced pressure. The solid was
redissolved in minimal dichloromethane and loaded onto a short
(10 cm) silica gel column. Residual ligand was eluted first with
dichloromethane, and then the metal species was eluted with acetone/
dichloromethane mixtures (1/3 v/v, then 1/2 v/v). It was necessary to
include NEt3 (1%) in the eluent, since the metal species was basic and
spread extensively as it traveled down the silica column. The product
fractions were selected by their yellow solution color, and the solvent
was removed. The solids were placed under high vacuum for 1.5 h, and
515 mg of a yellow solid was isolated (66%). Anal. Calcd (found) for
1
C30H26N2F6IrOCl: C, 46.66 (46.80); H, 3.39 (3.38); N, 3.63 (3.69). H
NMR (400 MHz, CD2Cl2): δ 8.95 (d, J = 6.0, 1H), 7.92 (m, 2H), 7.81 (s,
2H), 7.67 (s, 1H), 7.56 (dd, J = 8.0 and 1.6, 1H), 7.34 (td,
J = 6.0 and 3.2, 1H), 7.05 (td, J = 7.6 and 1.2, 1H), 6.93 (td, J = 7.6
and 1.2, 1H), 6.51 (d, J = 8.0, 1H), 1.41 (s, 15H). 13C{1H} NMR (150
MHz, CD2Cl2): δ 170.8, 156.0, 155.6, 150.4, 142.7, 139.1, 131.7, 130.7,
130.6 (q, 2-bond JC−F = 33), 130.4, 130.3, 128.6, 124.4, 123.7 (q, 1-bond
JC−F = 271), 122.6, 122.5 (pseudo t, 3-bond JC−F = 4), 122.4, 86.5, 8.7.
Synthesis of [Ir(Cp*){(3,5-bis(trifluoromethyl)benzoyl)(2-(2-
pyridyl)phenyl)amide}(NCArF)][B(ArF)4] (Int, 10). Complex 9
(150 mg, 0.19 mmol), 184 mg of Na[B(ArF)4] (0.21 mmol), NCArF
(3,5-bis(trifluoromethyl)benzonitrile, 35 μL, 0.21 mmol), and 20 mL
of dichloromethane were stirred for 3 h, at which point the mixture
Synthesis of [Ir(Cp*){(3,5-bis(trifluoromethyl)benzoyl)(2-(2-
pyridyl)phenyl)amide}(PPh3)][B(ArF)4] (13). Complex 9 (57 mg,
0.074 mmol), 72 mg of Na[B(ArF)4] (0.081 mmol), 21 mg of
triphenylphosphine (PPh3, 0.080 mmol), and 20 mL of dichloromethane
3992
dx.doi.org/10.1021/ja413023f | J. Am. Chem. Soc. 2014, 136, 3981−3994